» Authors » Michel Rivoire

Michel Rivoire

Explore the profile of Michel Rivoire including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 105
Citations 1675
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Collienne M, Neven A, Caballero C, Kataoka K, Carrion-Alvarez L, Nilsson H, et al.
Eur J Surg Oncol . 2023 Oct; 49(11):107081. PMID: 37793303
Aim: Multidisciplinary management of metastatic colorectal liver metastases (CRLM) is still challenging. To assess postoperative complications in initially unresectable or borderline resectable CRLM, the prospective EORTC-1409 ESSO 01-CLIMB trial capturing...
12.
Pividori M, Gangloff D, Ferron G, Meresse T, Delay E, Rivoire M, et al.
J Plast Reconstr Aesthet Surg . 2023 Aug; 85:242-251. PMID: 37531805
Background: Flap reconstruction is often required after pelvic tumor resection to reduce wound complications. The use of perforator flaps has been shown to reduce donor site morbidity. The purpose of...
13.
Dupre A, Rivoire M, Metzger S, Cropet C, Vincenot J, Peyrat P, et al.
Ultrasound Med Biol . 2023 Jun; 49(8):1845-1851. PMID: 37268553
Objective: High-intensity focused ultrasound (HIFU) is a recent, non-ionizing and non-invasive technology of focal destruction. Independence from the heat-sink effect of blood flow makes HIFU an interesting technique for focal...
14.
De Crignis L, Dupre A, Meeus P, Peyrat P, Rivoire M
Langenbecks Arch Surg . 2023 Jun; 408(1):221. PMID: 37261533
Purpose: Pelvic exenteration remains the only curative treatment for advanced pelvic malignancies. However, identification of predictive factors for successful surgical outcomes is still a controversial issue at present time. Methods:...
15.
Legrand A, Lucifora J, Lacombe B, Menard C, Michelet M, Foca A, et al.
Hepatol Commun . 2023 Apr; 7(5). PMID: 37058078
Background And Aims: HDV, a satellite of HBV, is responsible for the most severe form of human viral hepatitis, for which curative therapy is still awaited. Both HBV and HDV...
16.
Lucifora J, Alfaiate D, Pons C, Michelet M, Ramirez R, Fusil F, et al.
J Hepatol . 2023 Jan; 78(5):958-970. PMID: 36702177
Background & Aims: Chronic coinfection with HBV and HDV leads to the most aggressive form of chronic viral hepatitis. Herein, we aimed to elucidate the molecular mechanisms underlying the widely...
17.
Karam E, Tabutin M, Mastier C, De Crignis L, Peyrat P, Martin V, et al.
J Surg Oncol . 2022 Sep; 127(1):183-191. PMID: 36169242
Background: Pulmonary metastases (PM) are the most frequent extra-abdominal metastases from colorectal cancer. Lung resection and imaging-guided thermal ablation (IGTA) are used as curative-intent treatment. We compared the outcomes of...
18.
Desmares M, Delphin M, Chardes B, Pons C, Riedinger J, Michelet M, et al.
Antiviral Res . 2022 Aug; 206:105386. PMID: 35963549
Objectives: Pegylated-interferon-alpha (Peg-IFNα), an injectable innate immune protein, is still used to treat chronically HBV-infected patients, despite its poor tolerability. Peg-IFNα has the advantage over nucleos(t)ide analogues (NAs) to be...
19.
Claviere M, Lavedrine A, Lamiral G, Bonnet M, Verlhac P, Petkova D, et al.
Autophagy . 2022 Jul; 19(3):858-872. PMID: 35900944
Although it is admitted that secondary infection can complicate viral diseases, the consequences of viral infection on cell susceptibility to other infections remain underexplored at the cellular level. We though...
20.
Locatelli M, Quivy J, Chapus F, Michelet M, Fresquet J, Maadadi S, et al.
Cell Mol Gastroenterol Hepatol . 2022 Jun; 14(3):527-551. PMID: 35643233
Background & Aims: Upon hepatitis B virus (HBV) infection, partially double-stranded viral DNA converts into a covalently closed circular chromatinized episomal structure (cccDNA). This form represents the long-lived genomic reservoir...